This complex is regulated by the 4EBP1, a translational repressor that inhibits the function of eukaryotic translation initiation factor 4E (EIF4E), which compete with EIF4G1 for binding to eIF4E and have tumor-suppressor activity[21]. The gene discussed is EIF4EBP1; the disease is neoplasm.